Cargando…
TAOK1 Promotes Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells by Inhibition of WWC1
BACKGROUND: For patients with advanced non-small-cell lung cancer (NSCLC), targeted therapy significantly improves the therapeutic effect of NSCLC patients. With the development of molecular targeted therapy, more and more NSCLC-related genes have been found. Thousand and one amino-acid kinase 1 (TA...
Autor principal: | Chen, Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499761/ https://www.ncbi.nlm.nih.gov/pubmed/36158126 http://dx.doi.org/10.1155/2022/3157448 |
Ejemplares similares
-
FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells
por: Rong, Xuezhu, et al.
Publicado: (2019) -
WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
por: Han, Qiang, et al.
Publicado: (2021) -
WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
por: Han, Qiang, et al.
Publicado: (2018) -
WWC3 inhibits intimal proliferation following vascular injury via the Hippo signaling pathway
por: Chen, Beijia, et al.
Publicado: (2018) -
Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer
por: Yang, Li, et al.
Publicado: (2018)